Markets:

Overview

News

Currencies

International

Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

26.00 +1.94 (+8.06%)

Official Closing Price Updated: 7:00 PM EST, Nov 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

64 65 Next >

Kaplan Fox Reminds Investors of Hims & Hers Health, Inc. (NYSE: HIMS) of an Ongoing Investigation Into Potential Securities Law Violations

August 06, 2026

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

Lowey Dannenberg, P.C. is Investigating Hims & Hers Health, Inc. (NYSE: HIMS) for Potential Violations of the Federal Securities Laws

August 06, 2026

From Lowey Dannenberg, P.C.

Via GlobeNewswire

Hims & Hers Introduces New Hers App with First-of-Its-Kind, Doctor-Led, AI-Native Care Experience

August 06, 2026

From Hims & Hers

Via Business Wire

The FTC Is Suing Hims & Hers Health—Here's Why Investors Shouldn't Panic ↗

August 05, 2026

Hims & Hers Health shares have rallied despite an FTC lawsuit over data sharing and billing practices, as weight-loss drug partnerships and Wall Street's cautious Hold rating shape the stock's outlook...

Via MarketBeat

Topics Lawsuit

Kaplan Fox is Investigating Hims & Hers Health, Inc. (NYSE: HIMS) for Potential Securities Law Violations - Investors are Encouraged to Contact the Firm

August 04, 2026

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

Is Hims & Hers Health Stock in Trouble? ↗

August 03, 2026

In the past 12 months, the stock has nosedived more than 50%.

Via The Motley Fool

NYSE: HIMS Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages Hims & Hers Health, Inc. (NYSE: HIMS) Investors to Contact the Firm

August 03, 2026

From Kessler Topaz Meltzer & Check, LLP

Via Business Wire

Bearish Pressure Is Building Around These 3 Stocks ↗

August 03, 2026

Hims & Hers Health and QXO face heavy short interest amid dilution and loss concerns, while KLA has slid nearly 40% since June as AI-driven chip spending fears grip semiconductor stocks.

Via MarketBeat

Topics Artificial Intelligence

1 Russell 2000 Stock with Exciting Potential and 2 We Ignore

August 03, 2026

Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resou...

Via StockStory

Topics Economy

Kaplan Fox Encourages Investors of Hims & Hers Health, Inc. (NYSE: HIMS) to Contact the Firm Regarding an Investigation Into Possible Securities Law Violations

July 31, 2026

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

2 Growth Stocks with Explosive Upside and 1 That Underwhelm

July 31, 2026

Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 wil...

Via StockStory

Topics Artificial Intelligence

HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation with SBS Law

July 30, 2026

From Schall, Brown & Schwartz LLP

Via Business Wire

Securities Fraud Investigation Into Hims & Hers Health, Inc. (HIMS) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

July 30, 2026

From Glancy Prongay Wolke & Rotter LLP

Via Business Wire

Hims & Hers Health, Inc. (HIMS) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

July 30, 2026

From Law Offices of Howard G. Smith

Via Business Wire

2 Unprofitable Stocks for Long-Term Investors and 1 We Ignore

July 30, 2026

Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to conv...

Via StockStory

Topics Energy

Securities Fraud Investigation Into Hims & Hers Health, Inc. (HIMS) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

July 29, 2026

From The Law Offices of Frank R. Cruz

Via Business Wire

Hims & Hers Responds to FTC Lawsuit

July 29, 2026

From Hims & Hers

Via Business Wire

Hims & Hers Health, Repligen, West Pharmaceutical Services, and 10x Genomics Stocks Trade Down, What You Need To Know

July 24, 2026

What Happened? A number of stocks fell in the morning session after concerns grew over a rising number of uninsured patients. The trend was highlighted in HC...

Via StockStory

Why Is Hims & Hers Health Stock Surging on Thursday? ↗

July 23, 2026

Hims & Hers Health Inc (NYSE: HIMS) stock surges Thursday after an FDA advisory committee votes on adding BPC-157 to the allowed pharmacy compounding list.

Via Benzinga

1 Cash-Producing Stock to Target This Week and 2 Facing Headwinds

July 22, 2026

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Cas...

Via StockStory

Here’s How Much You Would Have Made Owning Hims & Hers Health Stock In The Last 5 Years ↗

July 21, 2026

Hims & Hers Health (NYSE:HIMS) has outperformed the market over the past 5 years by 20.67% on an annualized basis producing an average annual return of 31.83%. Currently, Hims & Hers Health has a...

Via Benzinga

Hims & Hers Chief Accounting Officer, Irene Becklund, Announces Departure from the Company

July 17, 2026

From Hims & Hers

Via Business Wire

3 Reasons HIMS Has Explosive Upside Potential

July 17, 2026

Hims & Hers Health trades at $33.39 per share and has stayed right on track with the overall market, gaining 9.6% over the last six months. At the same time,...

Via StockStory

Lowey Dannenberg, P.C. Investigates Hims & Hers Health, Inc. for Alleged Tracking of User Data

July 15, 2026

From Lowey Dannenberg, P.C.

Via GlobeNewswire

Hims & Hers to Announce Second Quarter 2026 Financial Results on August 10, 2026

July 13, 2026

From Hims & Hers

Via Business Wire

1 Stock Under $50 with Exciting Potential and 2 Facing Challenges

July 13, 2026

The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk tha...

Via StockStory

Hims & Hers Health vs. Teladoc Health: Which Healthcare Stock Is a Better Buy in 2026? ↗

July 06, 2026

One prioritizes rapid consumer growth and profitability; the other commands scale but faces concentration risk.

Via The Motley Fool

As Employers Drop Obesity Drug Coverage, Hims & Hers Could Be the Winner ↗

July 06, 2026

Hims & Hers Health shares have surged 45% in 30 days on GLP-1 coverage shifts, but overbought technicals, a Hold rating, and rising short interest suggest a pullback may be near.

Via MarketBeat

Here’s How Much You Would Have Made Owning Hims & Hers Health Stock In The Last 5 Years ↗

July 01, 2026

Hims & Hers Health (NYSE:HIMS) has outperformed the market over the past 5 years by 17.4% on an annualized basis producing an average annual return of 28.89%. Currently, Hims & Hers Health has a...

Via Benzinga

Hims & Hers Stock Surges as Analysts Lift Price Targets ↗

July 01, 2026

Hims & Hers Health Inc (NYSE:HIMS) shares are rising on Wenesday after B of A Securities and Canaccord Genuity raised their respective price targets on the stock.

Via Benzinga

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

64 65 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

All News about Hims & Hers Health, Inc. Class A Common Stock

Starting at /week.